BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 22309122)

  • 1. Polysaccharides serve as scaffold of biofilms formed by mucoid Pseudomonas aeruginosa.
    Yang L; Hengzhuang W; Wu H; Damkiaer S; Jochumsen N; Song Z; Givskov M; Høiby N; Molin S
    FEMS Immunol Med Microbiol; 2012 Jul; 65(2):366-76. PubMed ID: 22309122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of biofilm matrix polysaccharide Psl in mucoid Pseudomonas aeruginosa biofilms.
    Ma L; Wang S; Wang D; Parsek MR; Wozniak DJ
    FEMS Immunol Med Microbiol; 2012 Jul; 65(2):377-80. PubMed ID: 22309106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psl Produced by Mucoid
    Jones CJ; Wozniak DJ
    mBio; 2017 Jun; 8(3):. PubMed ID: 28634241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS
    APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
    Meluleni GJ; Grout M; Evans DJ; Pier GB
    J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron-regulated expression of alginate production, mucoid phenotype, and biofilm formation by Pseudomonas aeruginosa.
    Wiens JR; Vasil AI; Schurr MJ; Vasil ML
    mBio; 2014 Feb; 5(1):e01010-13. PubMed ID: 24496793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucoid Pseudomonas aeruginosa Can Produce Calcium-Gelled Biofilms Independent of the Matrix Components Psl and CdrA.
    Jacobs HM; O'Neal L; Lopatto E; Wozniak DJ; Bjarnsholt T; Parsek MR
    J Bacteriol; 2022 May; 204(5):e0056821. PubMed ID: 35416688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.
    Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N
    Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter-associated urinary tract infection by Pseudomonas aeruginosa is mediated by exopolysaccharide-independent biofilms.
    Cole SJ; Records AR; Orr MW; Linden SB; Lee VT
    Infect Immun; 2014 May; 82(5):2048-58. PubMed ID: 24595142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alginate acetylation influences initial surface colonization by mucoid Pseudomonas aeruginosa.
    Tielen P; Strathmann M; Jaeger KE; Flemming HC; Wingender J
    Microbiol Res; 2005; 160(2):165-76. PubMed ID: 15881834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa biofilms in cystic fibrosis.
    Høiby N; Ciofu O; Bjarnsholt T
    Future Microbiol; 2010 Nov; 5(11):1663-74. PubMed ID: 21133688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients.
    Lee B; Schjerling CK; Kirkby N; Hoffmann N; Borup R; Molin S; Høiby N; Ciofu O
    APMIS; 2011 Apr; 119(4-5):263-74. PubMed ID: 21492226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with mucoid transition of Pseudomonas aeruginosa in cystic fibrosis patients.
    Martha B; Croisier D; Fanton A; Astruc K; Piroth L; Huet F; Chavanet P
    Clin Microbiol Infect; 2010 Jun; 16(6):617-23. PubMed ID: 20002106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exopolysaccharide-Repressing Small Molecules with Antibiofilm and Antivirulence Activity against Pseudomonas aeruginosa.
    van Tilburg Bernardes E; Charron-Mazenod L; Reading DJ; Reckseidler-Zenteno SL; Lewenza S
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pel and Psl polysaccharides provide Pseudomonas aeruginosa structural redundancy within the biofilm matrix.
    Colvin KM; Irie Y; Tart CS; Urbano R; Whitney JC; Ryder C; Howell PL; Wozniak DJ; Parsek MR
    Environ Microbiol; 2012 Aug; 14(8):1913-28. PubMed ID: 22176658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
    Coban AY; Ciftci A; Onuk EE; Erturan Z; Tanriverdi Cayci Y; Durupinar B
    Mikrobiyol Bul; 2009 Oct; 43(4):563-73. PubMed ID: 20084909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of alginate in Pseudomonas aeruginosa EPS adherence, viscoelastic properties and cell attachment.
    Orgad O; Oren Y; Walker SL; Herzberg M
    Biofouling; 2011 Aug; 27(7):787-98. PubMed ID: 21797737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular DNA enhances biofilm integrity and mechanical properties of mucoid
    Ferguson DL; Gloag ES; Parsek MR; Wozniak DJ
    J Bacteriol; 2023 Oct; 205(10):e0023823. PubMed ID: 37791754
    [No Abstract]   [Full Text] [Related]  

  • 20. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS; Egan M; Kazmierczak BI
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.